Table 2.
Pharmacist responses to Questions 9, 14, 16, and 21.
| Pharmacists’ Suggestions of Training that Would Help them Feel Comfortable Providing Human Immunodeficiency Virus (HIV) Point-of-Care Testing (POCT) (Question 9) |
| • Substantially more additional training about HIV in general (n = 7, 27%) |
| • Hands-on experience with testing (n = 5, 19%) |
| • Support from corporate leadership (n = 5, 19%) |
| • More staff/labor hours (n = 3, 12%) |
| • Assistance with development of a collaborative drug therapy agreement (CDTA) (n = 2, 8%) |
| • A detailed implementation plan (n = 2, 8%) |
| • Training on talking to couples about reactive results (n = 1, 4%) |
| • Training for de-escalation during emotional situations (n = 1, 4%) |
| • And a motivational interviewing refresher course (n = 1, 4%) |
| Pharmacists’ opinions of the amount of time needed to conduct the HIV POCT, discuss results, and provide education and counseling if the test itself takes 5 min (Question 14) |
| • 5 to 10 min (n = 1, 4%) |
| • 15 to 20 min (n = 4, 15%) |
| • 20 to 30 min (n = 14, 54%) |
| • 30 to 45 min (n = 4, 15%) |
| • More than 45 min (n = 2, 8%) |
| • Prefer not to answer (n = 1, 4%) |
| Challenges to implementing HIV POCT beyond staffing time and physical space identified by pharmacist participants (Question 16) |
| • Corporate support for implementation (n = 4, 15%) |
| • Adding HIV POCT into workflow (n = 3, 12%) |
| • Advertising the service to the community (n = 2, 8%) |
| • Cost of testing and potential for reimbursement (n = 1, 4%) |
| Concerns regarding referring patients with a reactive screening and collaborating with community partners identified by pharmacist participants (Question 21) |
| • Ensuring patients followed up with another provider and not “falling between the cracks” (n = 3, 12%) |
| • Cost of testing and insurance coverage for testing and pre-exposure prophylaxis (PrEP)/post-exposure prophylaxis (PEP) (n = 2, 8%) |
| • Obtaining liver and kidney function blood tests prior to beginning PreP/PEP (n = 1, 4%) |
| • Limitations of the pharmacy’s computer system to document encounters (n = 1, 4%) |